Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Centus Biotherapeutics
Centus Biotherapeutics
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Equidacent
Bevacizumab
2020-09-24
Renal cell carcinoma
,
Colorectal neoplasms
,
Breast neoplasms
,
Ovarian neoplasms
,
Non-small-cell lung carcinoma
,
Glioblastoma
,
Fallopian tube neoplasms
,
Kidney neoplasms
,
Uterine cervical neoplasms
,
Peritoneal neoplasms
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Bevacizumab
healthy volunteers/patients
,
non-small-cell lung carcinoma
Bevifimod
sickle cell anemia
,
neoplasms
,
colonic neoplasms
,
adenocarcinoma
,
systemic lupus erythematosus
,
colorectal neoplasms
,
agammaglobulinemia
,
primary immunodeficiency diseases
,
von willebrand diseases
,
alzheimer disease
,
graft vs host disease
,
thrombocytopenic purpura idiopathic
,
protein c deficiency
,
leukemia
,
myeloid leukemia acute
,
non-hodgkin lymphoma
,
lymphoma
,
precursor cell lymphoblastic leukemia-lymphoma
,
b-cell chronic lymphocytic leukemia
,
hodgkin disease
,
b-cell lymphoma marginal zone
,
follicular lymphoma
,
mantle-cell lymphoma
,
myeloid leukemia chronic-phase
,
large b-cell lymphoma diffuse
,
myeloid leukemia accelerated phase
,
burkitt lymphoma
,
large-cell lymphoma immunoblastic
,
hemophilia b
,
thrombotic thrombocytopenic purpura
,
chronic obstructive pulmonary disease
,
dementia
,
mucocutaneous lymph node syndrome
,
immunologic deficiency syndromes
,
hemophilia a
,
alpha 1-antitrypsin deficiency
,
disease
,
healthy volunteers/patients
Globulin, immune
colorectal neoplasms
,
pancreatic neoplasms
,
stomach neoplasms
,
esophageal neoplasms
,
gastrointestinal stromal tumors
,
rectal neoplasms
,
mantle-cell lymphoma
,
reactive arthritis
,
lymphoma
,
b-cell lymphoma
,
non-hodgkin lymphoma
,
b-cell lymphoma marginal zone
,
waldenstrom macroglobulinemia
,
follicular lymphoma
,
hodgkin disease
,
sclerosis
,
b-cell chronic lymphocytic leukemia
,
lymphoid leukemia
,
leukemia
,
multiple sclerosis
Taxane
unknown primary neoplasms
,
squamous cell carcinoma of head and neck
,
renal cell carcinoma
,
liver neoplasms
,
biliary tract neoplasms
,
nasopharyngeal carcinoma
,
nasopharyngeal neoplasms
,
sex cord-gonadal stromal tumors
,
neuroendocrine carcinoma
,
triple negative breast neoplasms
,
neoplasms
,
ovarian neoplasms
,
stomach neoplasms
,
esophageal neoplasms
,
inflammatory breast neoplasms
,
ductal carcinoma breast
,
adenocarcinoma
,
neoplasm metastasis
,
castration-resistant prostatic neoplasms
,
neoplasms by site
,
lung neoplasms
,
mucinous adenocarcinoma
,
skin diseases
,
breast diseases
,
fallopian tube neoplasms
,
uterine cervical neoplasms
,
carcinoma
,
head and neck neoplasms
,
small cell lung carcinoma
,
peritoneal neoplasms
,
prostatic neoplasms
,
urinary bladder neoplasms
,
respiratory tract diseases
,
germ cell and embryonal neoplasms
,
lung diseases
,
respiratory tract neoplasms
,
bronchogenic carcinoma
,
thoracic neoplasms
,
bronchial diseases
,
neoplasms by histologic type
,
nerve tissue neoplasms
,
patient preference
,
ovarian epithelial carcinoma
,
lobular carcinoma
,
endometrial neoplasms
,
breast neoplasms
,
non-small-cell lung carcinoma
,
colonic neoplasms
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use